2 Reasons to Watch GMED and 1 to Stay Cautious

Over the past six months, Globus Medical’s shares (currently trading at $79.99) have posted a disappointing 10.1% loss, well below the S&P 500’s 10.7% gain. This might have investors contemplating their next move.